DRIVIN G ROWTH - Dr. Reddy's

134
cash flow statement | (contd...) YEAR ENDED MARCH 31
(All amounts in Indian Rupees thousands, except share data)
2002 2001
Cash flows from financing activities
Proceeds from issuance of share capital (net of share issue expenses) 5,782,725 –
Repayment of debentures (300,000) (3,000)
Proceeds from long-term borrowings 13,188 –
Repayment of long-term borrowings (900,422) (405,781)
Repayment of short-term borrowings (2,428,996) 208,148
Interest paid (161,437) (418,445)
Dividends paid (560,846) (138,282)
Net cash provided by financing activities 1,444,212 (757,360)
Net increase in cash and cash equivalents 4,600,630 (101,130)
Cash and cash equivalents at the beginning of the period (Note 1) 194,308 295,438
Effect of exchange gain on cash and cash equivalents 90,663 –
Cash and cash equivalents at the end of the period (Note 1) 4,885,601 194,308
NOTES
1. Cash and cash equivalents comprise
Cash on hand 1,818 3,111
Balances in
Current accounts 90,710 56,961
Deposit accounts 4,768,935 8,849
EEFC current accounts 7,540 116,278
Unclaimed dividend 9,541 5,074
Unclaimed fractional share pay order accounts 727 –
Margin money 6,330 4,035
2. During the current year 113,388 equity shares of Rs. 5 each have been allotted
pursuant to the scheme of amalgamation of American Remedies Limited with
the Company, without payment being received in cash.
3. Previous year’s figures have been regrouped / reclassified, wherever necessary to
conform to the current year’s classification.
DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002
4,885,601 194,308